In terms of cell-mediated immunity, no significant differences were found in CD3, CD4, CD8, CD19 between the two groups of patients, only NK cells were higher in non-HLH patients than HLH patients (P = 0.033). The gene discussed is CD19; the disease is hemophagocytic syndrome.